About: Intramuscular oxytocin versus oxytocin/ergometrine versus carbetocin for prevention of primary postpartum haemorrhage after vaginal birth: study protocol for a randomised controlled trial (the IMox study)

Facets (new session)
Description
Metadata
Settings
- owl:sameAs
- Inference Rule:

About: Intramuscular oxytocin versus oxytocin/ergometrine versus carbetocin for prevention of primary postpartum haemorrhage after vaginal birth: study protocol for a randomised controlled trial (the IMox study) Goto Sponge NotDistinct Permalink

An Entity of Type : wikibase:Item, within Data Space : wikidata.demo.openlinksw.com associated with source document(s)

scientific article published on 03 January 2019

Attributes	Values
rdf:type	Item
description	wetenschappelijk artikel (nl) наукова стаття, опублікована в січні 2019 (uk) article scientifique publié en 2019 (fr) artículu científicu espublizáu en xineru de 2019 (ast) im Januar 2019 veröffentlichter wissenschaftlicher Artikel (de) scientific article published on 03 January 2019 (en)
publication date	wds:Q60922092-00FFAC53-A095-4521-9D26-7266113BB0A1
publication date	2019-01-03 00:00:00Z (xsd:dateTime)
language of work or name	wds:Q60922092-FE9548C2-8CA2-4E77-B8A5-9AE2A25BDAC8
language of work or name	English
exact match	wds:Q60922092-CBF0FA3C-B0BB-49FE-9FFC-DAAF125BFBC4
exact match	https://scigraph.springernature.com/pub.10.1186/s13063-018-3109-2
cites work	wds:Q60922092-04DA47CE-47A5-47CF-B69A-438EB3160B49 wds:Q60922092-14C8786B-D435-4ADA-9BD4-D57C1DC6E136 wds:Q60922092-3A33720A-67AD-4CDF-A0AC-B22B48655514 wds:Q60922092-53F56BBD-AB94-4080-8614-C80AE7F50677 wds:Q60922092-63869312-510C-4DC5-AC07-91A4F03652ED wds:Q60922092-663996FE-E867-43E1-8F33-6446588B2A07 wds:Q60922092-6687C894-0240-4B0B-9426-AD8F1AD164E7 wds:Q60922092-6751714D-5D08-4B69-A3B1-1623BF86EB70 wds:Q60922092-725EBFD6-EBAA-4AA1-9EB7-B480A281A586 wds:Q60922092-7EA0E086-617E-44C8-AB44-2365368CA8B6 wds:Q60922092-88182D1F-65C3-44CE-A3AB-74F7CA37889C wds:Q60922092-9FCFC56C-9B22-4A40-B764-C361A4BD5DBB wds:Q60922092-A8CC7546-1499-4922-921B-E554D7C700C7 wds:Q60922092-A909024C-0401-4884-AA61-5D07CED9C99D wds:Q60922092-E4906A0B-8D02-46F1-B9C6-BEEE21276FEC wds:Q60922092-EEDAA399-D32B-44B7-A6BB-553CF2B359DE wds:Q60922092-F05B7B81-E512-4AFB-A5EF-0F51890EB215 wds:Q60922092-F6AFC28D-D9E3-4BAB-9DE7-3F8ED09DF7A1 wds:Q60922092-FC3164AB-7061-4D52-8095-C499106AE183
cites work	SPIRIT 2013 statement: defining standard protocol items for clinical trials Global causes of maternal death: a WHO systematic analysis Prophylactic ergometrine-oxytocin versus oxytocin for the third stage of labour CONSORT 2010 statement: updated guidelines for reporting parallel group randomised trials Active versus expectant management for women in the third stage of labour Committee for Medicinal Products for Human Use (CHMP) guideline on the choice of the non-inferiority margin Joint statement: management of the third stage of labour to prevent post-partum haemorrhage Joint statement: management of the third stage of labour to prevent post-partum haemorrhage Improving the accuracy of estimated blood loss at obstetric haemorrhage using clinical reconstructions Emotional and physical health outcomes after significant primary post-partum haemorrhage (PPH): a multicentre cohort study Discrepancy between laboratory determination and visual estimation of blood loss during normal delivery Postpartum hemorrhage: epidemiology, risk factors, and causes Estimating mean QALYs in trial-based cost-effectiveness analysis: the importance of controlling for baseline utility Statistical principles for clinical trials (ICH E9): an introductory note on an international guideline. Uterotonic agents for preventing postpartum haemorrhage: a network meta-analysis. Oxytocin receptor binding and uterotonic activity of carbetocin and its metabolites following enzymatic degradation Heat-Stable Carbetocin versus Oxytocin to Prevent Hemorrhage after Vaginal Birth Core outcome sets for prevention and treatment of postpartum haemorrhage: an international Delphi consensus study Prevention and Management of Postpartum Haemorrhage
author name string	wds:Q60922092-367B0B1B-249D-455D-BCF9-3B5F067B5906 wds:Q60922092-4CA2C120-2137-4B58-849B-B9114B61DF15 wds:Q60922092-60D2BE9F-63C9-431D-9F8D-B9244DCE3A40 wds:Q60922092-8FA262E1-289E-4439-9741-B191FC82EBB9 wds:Q60922092-97FDF4AD-DC6F-4FB8-85CE-6BDD46A8F977 wds:Q60922092-9F2D21FB-8D98-4E01-9ACA-5C9B6C1CEC7F
author name string	Erik Lenguerrand Timothy Draycott Helen van der Nelson Michelle Mayer Mary Alvarez Sara Burnard
rdfs:label	Intramuscular oxytocin versus oxytocin/ergometrine versus carbetocin for prevention of primary postpartum haemorrhage after vaginal birth: study protocol for a randomised controlled trial (nl) Intramuscular oxytocin versus oxytocin/ergometrine versus carbetocin for prevention of primary postpartum haemorrhage after vaginal birth: study protocol for a randomised controlled trial (the IMox study) (en)
skos:prefLabel	Intramuscular oxytocin versus oxytocin/ergometrine versus carbetocin for prevention of primary postpartum haemorrhage after vaginal birth: study protocol for a randomised controlled trial (nl) Intramuscular oxytocin versus oxytocin/ergometrine versus carbetocin for prevention of primary postpartum haemorrhage after vaginal birth: study protocol for a randomised controlled trial (the IMox study) (en)
name	Intramuscular oxytocin versus oxytocin/ergometrine versus carbetocin for prevention of primary postpartum haemorrhage after vaginal birth: study protocol for a randomised controlled trial (nl) Intramuscular oxytocin versus oxytocin/ergometrine versus carbetocin for prevention of primary postpartum haemorrhage after vaginal birth: study protocol for a randomised controlled trial (the IMox study) (en)
author	wds:Q60922092-099D8784-3061-4266-816D-38DE1DB4D3D3 wds:Q60922092-64DF5B27-91F5-4FB5-B1F6-CDE9489408E4 wds:Q60922092-ACF81B3E-2369-4598-B6BF-6E2B37D396BE
author	Elsa Marques Dimitrios Siassakos Stephen O'Brien
title	wds:Q60922092-78C4D134-2CB5-405F-AA72-2AE707946F77
title	Intramuscular oxytocin versus oxytocin/ergometrine versus carbetocin for prevention of primary postpartum haemorrhage after vaginal birth: study protocol for a randomised controlled trial (the IMox study) (en)
page(s)	wds:Q60922092-EFD36948-6829-4206-AFE2-6F361920F9B2
page(s)	4
instance of	wds:Q60922092-8EE5B072-A252-4F48-88F2-029A969AEBA6
instance of	scholarly article
main subject	wds:Q60922092-A73C2C84-90BF-4C04-8C4A-499D0D5B4406 wds:Q60922092-F89B4CA2-8C74-413F-83B8-CCBC0D394C06
main subject	oxytocin study protocol
PubMed ID	wds:Q60922092-0D0E35E7-7E19-4C9C-BD38-252D5ACE2B70
PubMed ID	http://rdf.ncbi.nlm.nih.gov/pubchem/reference/30606246
PubMed ID	30606246
published in	wds:Q60922092-B14D5A34-3C1F-43A6-9080-7E01762E6878
published in	Trials
issue	wds:Q60922092-AE296784-1C03-422C-9AF6-BA191F5F8AE3
volume	wds:Q60922092-9BEF89CA-34E3-439C-989B-206620155D31
issue	1
volume	20
DOI	wds:Q60922092-B300FAF2-55F6-4AFA-8388-B2A54846CA7C
DOI	http://dx.doi.org/10.1186/S13063-018-3109-2
DOI	10.1186/S13063-018-3109-2
copyright license	wds:Q60922092-3311eedd-b657-403f-98ae-db76913268fe
copyright status	wds:Q60922092-819bcbd8-3b38-48c5-9f10-e0e7b58c7957
copyright license	Creative Commons Attribution 4.0 International

Faceted Search & Find service v1.16.117 as of May 05 2024

Alternative Linked Data Documents: ODE Content Formats:

RDF

ODATA

Microdata

About

OpenLink Virtuoso version 07.20.3239 as of May 5 2024, on Linux (x86_64-centos_6-linux-gnu), Single-Server Edition (378 GB total memory, 193 GB memory in use)
Data on this page belongs to its respective rights holders.
Virtuoso Faceted Browser Copyright © 2009-2024 OpenLink Software